Company Statement: Investor and EQT to sell Gambro to Baxter
MLex Summary: Private equity companies Investor and EQT IV have signed an agreement to divest Gambro to the medical technology firm Baxter for four billion dollars. The transaction is subject to...To view the full article, register now.
Already a subscriber? Click here to view full article